EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies

Housaiyin Li, Dan P Zandberg, Aditi Kulkarni, Simion I Chiosea, Patricia M Santos, Brian R Isett, Marion Joy, Gabriel L Sica, Kevin J Contrera, Curtis M Tatsuoka, Matthias Brand, Umamaheswar Duvvuri und 12 weitere

Cancer Cell · 2025-04 · 43 (4) · 757-775.e8

DOI: 10.1016/j.ccell.2025.02.026 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Cancer Cell, 2025-04. Verfasst von Housaiyin Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Molecular Genetics a…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Head and Neck Neoplasms, Immune Checkpoint Inhibitors, Immunotherapy. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesHead and Neck NeoplasmsImmune Checkpoint InhibitorsImmunotherapyLymphocytes, Tumor-InfiltratingNeoadjuvant TherapySquamous Cell Carcinoma of Head and NeckFemaleHumansMaleCTLA-4 AntigenImmunologic MemoryLymphocyte Activation Gene 3 ProteinProgrammed Cell Death 1 Receptor

Stichwörter der Autor:innen

CTLA-4Head and neck cancerLAG-3PD-1T cell dynamicsclinical trialcombination immunotherapymultispectral imagingsingle-cell genomicstumor immunology

Substanzen

CTLA-4 AntigenImmune Checkpoint InhibitorsLag3 protein, humanLymphocyte Activation Gene 3 ProteinProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Molecular Genetics and Development Biology Graduate Program, University of Pittsburgh, Pit…
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIDCR NIH HHS
  • University of Pittsburgh
  • National Institutes of Health National Cancer Institute
  • California Department of Fish and Game
  • National Institutes of Health
  • Bristol-Myers Squibb

Zitieren

APA

Li, H., Zandberg, D. P., Kulkarni, A., Chiosea, S. I., Santos, P. M., Isett, B. R., Joy, M., Sica, G. L., Contrera, K. J., Tatsuoka, C. M., Brand, M., Duvvuri, U., Kim, S., Kubik, M., Sridharan, S., Tu, F., Chen, J., Bruno, T. C., Vignali, D. A. A., …, & Ferris, R. L. (2025). Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies. Cancer Cell, 43(4), 757-775.e8. https://doi.org/10.1016/j.ccell.2025.02.026

Vancouver

Li H, Zandberg DP, Kulkarni A, Chiosea SI, Santos PM, Isett BR, et al. Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies. Cancer Cell. 2025;43(4):757-775.e8. doi:10.1016/j.ccell.2025.02.026

BibTeX
@article{Li2025,
  author = {Li, Housaiyin and Zandberg, Dan P and Kulkarni, Aditi and Chiosea, Simion I and Santos, Patricia M and Isett, Brian R and Joy, Marion and Sica, Gabriel L and Contrera, Kevin J and Tatsuoka, Curtis M and Brand, Matthias and Duvvuri, Umamaheswar and Kim, Seungwon and Kubik, Mark and Sridharan, Shaum and Tu, Fei and Chen, Jie and Bruno, Tullia C and Vignali, Dario A A and Cillo, Anthony R and Bao, Riyue and Wang, Jing Hong and Vujanovic, Lazar and Ferris, Robert L},
  title = {Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {4},
  pages = {757--775.e8},
  doi = {10.1016/j.ccell.2025.02.026}
}
Kostenlos starten →